{
    "Trade/Device Name(s)": [
        "MicroScan\u00ae MICroSTREP plus\u00ae Panels",
        "MicroScan\u00ae MICroSTREP plus\u00ae with Daptomycin"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics",
    "510(k) Number": "K111394",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020556"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LTT",
        "LTW",
        "JWY",
        "LRG"
    ],
    "Summary Letter Date": "May 16, 2011",
    "Summary Letter Received Date": "May 25, 2011",
    "Submission Date": "May 12, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test (AST) Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Daptomycin"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of aerobic streptococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan\u00ae WalkAway System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Microdilution panels"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan\u00ae MICroSTREP plus\u00ae Panels with Daptomycin for determining antimicrobial susceptibility of aerobic streptococci.",
    "Indications for Use Summary": "Determines quantitative and/or qualitative antimicrobial agent susceptibility of aerobic streptococci colonies grown on solid media, specifically for Daptomycin, including S. pyogenes, S. agalactiae, and S. dysglactiae subsp. equisimilis.",
    "fda_folder": "Microbiology"
}